āĻļāĻŋāĻ˛ā§āĻĒ āύāĻŋāĻ°ā§āĻĻ⧇āĻļāĻŋāĻ•āĻž

āϰ⧇āĻĄāĻŋāĻ“āϞāϜāĻŋāϤ⧇ āĻāφāχ

Radiology AI analyzes imaging data for specific intended uses such as segmentation, detection, prioritization or decision support.

āĻāχ āύāĻŋāĻ°ā§āĻĻ⧇āĻļāĻŋāĻ•āĻž āĻļ⧁āύ⧁āύāĻāφāχ-āĻŦāĻ°ā§āĻŖāĻŋāϤ ¡ ~2 min

āĻāχ āĻĒ⧃āĻˇā§āĻ āĻžāϝāĻŧ2 āĻŽāĻŋāύāĻŋāϟ āĻĒāĻ āĻŋāϤ
  1. āĻ“āĻ­āĻžāϰāĻ­āĻŋāω
  2. āĻ—āĻ­ā§€āϰ āĻĄā§āĻŦ
  3. āĻŦāĻžāĻ¸ā§āϤāĻŦ-āĻŦāĻŋāĻļā§āĻŦ āĻŦāĻžāĻ¸ā§āϤāĻŦāĻžāϝāĻŧāύ
  4. āϰ⧇āĻĄāĻŋāĻ“āϞāϜāĻŋāϤ⧇ AI āĻāϰ āĻ­āĻŦāĻŋāĻˇā§āϝāϤ
  5. āĻāϟāĻžāϕ⧇ āĻŦāĻžāĻ¸ā§āϤāĻŦ⧇ āĻĒā§āϰāϝāĻŧā§‹āĻ— āĻ•āϰāĻž āĻšāĻšā§āϛ⧇
  6. āĻ…āĻ¨ā§āĻŦ⧇āώāĻŖ āϚāĻžāϞāĻŋāϝāĻŧ⧇ āϝāĻžāύ
  7. āĻĒā§āϰāĻžāϝāĻŧāĻļāχ āϜāĻŋāĻœā§āĻžāĻžāϏāĻŋāϤ āĻĒā§āϰāĻļā§āύāĻžāĻŦāϞ⧀

āĻ“āĻ­āĻžāϰāĻ­āĻŋāω

Performance and authorization are specific to a device, population and workflow.

āĻ—āĻ­ā§€āϰ āĻĄā§āĻŦ

Convolutional neural networks apply local filters to image data; U-Net uses an encoder-decoder with skip connections for biomedical segmentation. FDA device listings specify particular cleared or authorized intended uses, not approval for all radiology tasks. The ScreenTrustCAD trial was a prospective paired-reader study in mammography: each examination was independently interpreted by two radiologists and AI CAD, then selected cases went to consensus discussion. These examples are task-specific and do not establish universal clinical performance or deployment prevalence. Diagnostic evaluation metrics include sensitivity (the fraction of affected cases correctly identified), specificity (the fraction of unaffected cases correctly identified), and AUC (threshold-independent ranking discrimination). These metrics summarize different properties and do not guarantee performance in another population. The 2025 ScreenTrustCAD human-AI interaction analysis included 54,991 women, according to the PubMed abstract. This count describes the analytic cohort reported in that analysis.

āĻŦāĻžāĻ¸ā§āϤāĻŦ-āĻŦāĻŋāĻļā§āĻŦ āĻŦāĻžāĻ¸ā§āϤāĻŦāĻžāϝāĻŧāύ

U-Net is a convolutional encoder-decoder architecture developed for biomedical image segmentation.

FDA’s AI-enabled device list identifies devices and their cleared or authorized intended uses.

A worklist-prioritization step is a possible design for urgent findings, with a radiologist responsible for interpretation.

ScreenTrustCAD prospectively compared AI CAD and radiologist readings of screening mammograms in 55,581 women.

āϰ⧇āĻĄāĻŋāĻ“āϞāϜāĻŋāϤ⧇ AI āĻāϰ āĻ­āĻŦāĻŋāĻˇā§āϝāϤ

Evaluate an imaging model for its specific intended use, patient population and workflow. FDA authorization applies to the device’s specified use and does not establish performance for every site, scanner or clinical decision.

āĻāϟāĻžāϕ⧇ āĻŦāĻžāĻ¸ā§āϤāĻŦ⧇ āĻĒā§āϰāϝāĻŧā§‹āĻ— āĻ•āϰāĻž āĻšāĻšā§āϛ⧇

āϕ⧇āύ āĻāϟāĻž āϗ⧁āϰ⧁āĻ¤ā§āĻŦāĻĒā§‚āĻ°ā§āĻŖ

  • āĻĒā§āϰāϏāĻ™ā§āĻ— āĻāĻŦāĻ‚ āύāĻŋāϝāĻŧāĻŽ. āĻļāĻŋāĻ˛ā§āĻĒ⧇āϰ āĻĒā§āϰ⧇āĻ•ā§āώāĻžāĻĒāϟ āύāĻŋāĻ°ā§āϧāĻžāϰāĻŖ āĻ•āϰ⧇ āϝ⧇ āĻāφāχ āϧāĻžāϰāĻŖāĻž āĻŦāĻžāĻ¸ā§āϤāĻŦāϤāĻžāϰ āϏāĻžāĻĨ⧇ āϝ⧋āĻ—āĻžāϝ⧋āĻ— āϰāĻ•ā§āώāĻž āĻ•āϰ⧇āĨ¤
  • āĻŽāĻžāύ āύāĻŋāϝāĻŧāĻ¨ā§āĻ¤ā§āϰāĻŖ. āĻĄā§‹āĻŽā§‡āύ⧇āϰ āϏ⧀āĻŽāĻžāĻŦāĻĻā§āϧāϤāĻž āĻ—ā§āϰāĻšāĻŖāϝ⧋āĻ—ā§āϝ āĻ¤ā§āϰ⧁āϟāĻŋāϰ āĻšāĻžāϰ āĻāĻŦāĻ‚ āϤāĻĻāĻžāϰāĻ•āĻŋ āĻŽāĻĄā§‡āϞāϗ⧁āϞāĻŋāϕ⧇ āĻĒā§āϰāĻ­āĻžāĻŦāĻŋāϤ āĻ•āϰ⧇āĨ¤
  • āĻĒāĻ›āĻ¨ā§āĻĻāϗ⧁āϞāĻŋ āϤ⧈āϰāĻŋ āĻ•āϰ⧁āύ. āϏāĻĢāϞ āĻ¸ā§āĻĨāĻžāĻĒāύāĻž āĻĒā§āϰāϝ⧁āĻ•ā§āϤāĻŋāĻ—āϤ āĻ•ā§āώāĻŽāϤāĻžāϕ⧇ āĻĢā§āϰāĻ¨ā§āϟāϞāĻžāχāύ āĻ“āϝāĻŧāĻžāĻ°ā§āĻ•āĻĢā§āϞ⧋āϗ⧁āϞāĻŋāϰ āϏāĻžāĻĨ⧇ āϏāĻžāϰāĻŋāĻŦāĻĻā§āϧ āĻ•āϰ⧇āĨ¤

āϜāĻ¨ā§āϝ āϏāϤāĻ°ā§āĻ•

  • āύāĻŋāϝāĻŧāĻ¨ā§āĻ¤ā§āϰāĻ• āĻĒā§āϰāϝāĻŧā§‹āϜāύ⧀āϝāĻŧāϤāĻž āĻ…āĻ¨ā§āϝāĻĨāĻžāϝāĻŧ āĻļāĻ•ā§āϤāĻŋāĻļāĻžāϞ⧀ āĻĒā§āϰ⧋āĻŸā§‹āϟāĻžāχāĻĒ āĻŦāĻžāϤāĻŋāϞ āĻ•āϰāϤ⧇ āĻĒāĻžāϰ⧇āĨ¤
  • āϐāϤāĻŋāĻšāĻžāϏāĻŋāĻ• āĻĄā§‡āϟāĻž āĻāĻŽāύ āĻĒāĻ•ā§āώāĻĒāĻžāϤ āĻāύāϕ⧋āĻĄ āĻ•āϰāϤ⧇ āĻĒāĻžāϰ⧇ āϝāĻž āύāĻŋāĻ°ā§āĻĻāĻŋāĻˇā§āϟ āϏāĻŽā§āĻĒā§āϰāĻĻāĻžāϝāĻŧ⧇āϰ āĻ•ā§āώāϤāĻŋ āĻ•āϰ⧇āĨ¤
  • āϞāĻŋāĻ—ā§āϝāĻžāϏāĻŋ āϏāĻŋāĻ¸ā§āĻŸā§‡āĻŽāϗ⧁āϞāĻŋ āχāĻ¨ā§āϟāĻŋāĻ—ā§āϰ⧇āĻļāύ āĻŦāĻžāϧāĻž āĻāĻŦāĻ‚ āϞ⧁āĻ•āĻžāύ⧋ āĻ–āϰāϚ āϤ⧈āϰāĻŋ āĻ•āϰāϤ⧇ āĻĒāĻžāϰ⧇āĨ¤

āĻĒāϰāĻŦāĻ°ā§āϤ⧀ āĻĒāĻĻāĻ•ā§āώ⧇āĻĒ

  1. āϏāĻŽāĻ¸ā§āϝāĻž āĻĢā§āϰ⧇āĻŽāĻŋāĻ‚ āĻĨ⧇āϕ⧇ āĻŽā§‚āĻ˛ā§āϝāĻžāϝāĻŧāύ āĻĒāĻ°ā§āϝāĻ¨ā§āϤ āĻĄā§‹āĻŽā§‡āύ āĻŦāĻŋāĻļ⧇āώāĻœā§āĻžāĻĻ⧇āϰ āϜāĻĄāĻŧāĻŋāϤ āĻ•āϰ⧁āύāĨ¤
  2. āϞāĻžā§āĻšā§‡āϰ āφāϗ⧇ āĻ…āĻĄāĻŋāϟ āĻŸā§āϰ⧇āχāϞ āĻāĻŦāĻ‚ āĻĄāϕ⧁āĻŽā§‡āĻ¨ā§āĻŸā§‡āĻļāύ āĻĄāĻŋāϜāĻžāχāύ āĻ•āϰ⧁āύāĨ¤
  3. āϏāĻŽā§āĻŽāϤāĻŋ āĻāĻŦāĻ‚ āύāĻŋāϰāĻžāĻĒāĻ¤ā§āϤāĻž āĻŦāĻžāĻ§ā§āϝāĻŦāĻžāϧāĻ•āϤāĻžāϗ⧁āϞāĻŋ āϤāĻžāĻĄāĻŧāĻžāϤāĻžāĻĄāĻŧāĻŋ āϝāĻžāϚāĻžāχ āĻ•āϰ⧁āύāĨ¤
  4. āĻĒāϰāĻŋāĻˇā§āĻ•āĻžāϰ āĻ¸ā§āϟāĻĒ āĻāĻŦāĻ‚ āϰ⧋āϞāĻŦā§āϝāĻžāĻ• āĻŽāĻžāύāĻĻāĻŖā§āĻĄā§‡āϰ āϏāĻžāĻĨ⧇ āĻĒāĻ°ā§āϝāĻžāϝāĻŧāĻ•ā§āϰāĻŽā§‡ āϰ⧋āϞ āφāωāϟ āĻ•āϰ⧁āύāĨ¤

āĻ…āĻ¨ā§āĻŦ⧇āώāĻŖ āϚāĻžāϞāĻŋāϝāĻŧ⧇ āϝāĻžāύ

āĻĢā§āϰāĻŋ āύāĻŋāωāϜāϞ⧇āϟāĻžāϰ

āĻĒā§āϰāϤāĻŋāĻĻāĻŋāύ⧇āϰ āĻāφāχ āĻŦā§āϰāĻŋāĻĢāĻŋāĻ‚ āĻĒāĻžāύ

āĻĒā§āϰāϤāĻŋ āϏāĻĒā§āϤāĻžāĻšā§‡āϰ āĻ•āĻžāĻœā§‡āϰ āĻĻāĻŋāύ āϏāĻ•āĻžāϞ⧇ āϤāĻŋāύāϟāĻŋ āϝāĻžāϚāĻžāχāĻ•ā§ƒāϤ āĻāφāχ āĻ¸ā§āĻŸā§‹āϰāĻŋ, āϏāĻšāϜ āχāĻ‚āϰ⧇āϜāĻŋāϤ⧇ āϞ⧇āĻ–āĻžāĨ¤ āϚāĻŋāϰāĻ•āĻžāϞ⧇āϰ āϜāĻ¨ā§āϝ āĻĢā§āϰāĻŋ, āϕ⧋āύ⧋ āĻŦāĻŋāĻœā§āĻžāĻžāĻĒāύ āύ⧇āχāĨ¤

āĻĒā§āϰāϤāĻŋ āϏāĻĒā§āϤāĻžāĻšā§‡āϰ āĻ•āĻžāĻœā§‡āϰ āĻĻāĻŋāύ⧇ āĻāĻ•āϟāĻŋ āχāĻŽā§‡āϞāĨ¤ āĻāĻ• āĻ•ā§āϞāĻŋāϕ⧇āχ āφāύāϏāĻžāĻŦāĻ¸ā§āĻ•ā§āϰāĻžāχāĻŦ āĻ•āϰ⧁āύāĨ¤ āφāĻŽāϰāĻž āĻ•āĻ–āύ⧋āχ āφāĻĒāύāĻžāϰ āĻ āĻŋāĻ•āĻžāύāĻž āĻŦāĻŋāĻ•ā§āϰāĻŋ āĻŦāĻž āĻļā§‡ā§ŸāĻžāϰ āĻ•āϰāĻŋ āύāĻžāĨ¤

āύāĻŋāĻœā§‡āϕ⧇ āĻĒāϰ⧀āĻ•ā§āώāĻž āĻ•āϰ⧁āύ

Take the AI in Radiology quiz

āĻĒā§āϰāϤāĻŋāϟāĻŋ āωāĻ¤ā§āϤāϰ⧇āϰ āϤāĻžā§ŽāĻ•ā§āώāĻŖāĻŋāĻ• āĻĢāĻŋāĻĄāĻŦā§āϝāĻžāĻ•, āĻāĻŦāĻ‚ āϕ⧋āĻ°ā§āϏ āĻĒāĻžāϏ āĻ•āϰāĻžāϰ āĻĒāϰ āϝāĻžāϚāĻžāχāϝ⧋āĻ—ā§āϝ āφāχāĻĄāĻŋ āϏāĻš āĻāĻ•āϟāĻŋ āĻļā§‡ā§ŸāĻžāϰāϝ⧋āĻ—ā§āϝ āϏāĻžāĻ°ā§āϟāĻŋāĻĢāĻŋāϕ⧇āϟāĨ¤

āϕ⧁āχāϜ āĻļ⧁āϰ⧁ āĻ•āϰ⧁āύ

āĻĢā§āϰāĻŋ āĻāφāχ āĻļāĻŋāĻ•ā§āώāĻžāϕ⧇ āϏāĻŽāĻ°ā§āĻĨāύ āĻ•āϰ⧁āύāĨ¤ AI Understanding āĻāĻ•āϟāĻŋ 501(c)(3) āĻ…āϞāĻžāĻ­āϜāύāĻ• āĻĒā§āϰāϤāĻŋāĻˇā§āĻ āĻžāύ — āϕ⧋āύ⧋ āĻŦāĻŋāĻœā§āĻžāĻžāĻĒāύ āύ⧇āχ, āϕ⧋āύ⧋ āĻĒ⧇āĻ“ā§ŸāĻžāϞ āύ⧇āχ, āĻ•āĻ–āύ⧋āχ āύāĻžāĨ¤ āĻāĻ•āϟāĻŋ āĻĻāĻžāύ āĻ•āϰ⧁āύ

āĻĒā§āϰāĻžāϝāĻŧāĻļāχ āϜāĻŋāĻœā§āĻžāĻžāϏāĻŋāϤ āĻĒā§āϰāĻļā§āύāĻžāĻŦāϞ⧀

What is AI in Radiology?

Radiology AI analyzes imaging data for specific intended uses such as segmentation, detection, prioritization or decision support. Performance and authorization are specific to a device, population and workflow.

What operation lets a convolutional neural network detect local image patterns in radiology images?

Convolutional networks apply learned filters across local image regions. The U-Net paper is a primary medical-image example; this is a mechanism, not a prevalence claim.

What is a possible worklist use of a radiology AI model?

Prioritizing suspected urgent findings is a possible workflow design, not a claim that FDA-authorized systems generally perform this role or replace radiologist review.

āϰ⧇āĻĄāĻŋāĻ“āϞāϜāĻŋ āĻāφāχ-āϤ⧇ 'āĻĄā§‹āĻŽā§‡āύ āĻļāĻŋāĻĢāϟ' āϕ⧀ āĻŦā§‹āĻāĻžāϝāĻŧ?

Domain shift means the deployment-data distribution differs from the training or evaluation distribution. That difference can change measured performance, but a shift does not guarantee a specific decrease in every setting.

āϕ⧋āύ āĻ¸ā§āĻĨāĻžāĻĒāĻ¤ā§āϝāϟāĻŋ āϏāĻžāϧāĻžāϰāĻŖāϤ āĻĒāĻŋāĻ•ā§āϏ⧇āϞ āĻĻā§āĻŦāĻžāϰāĻž āĻāĻ•āϟāĻŋ āϟāĻŋāωāĻŽāĻžāϰ āĻĒāĻŋāĻ•ā§āϏ⧇āϞ āϰ⧂āĻĒāϰ⧇āĻ–āĻž (āϏ⧇āĻ—āĻŽā§‡āĻ¨ā§āϟ) āĻ•āϰāϤ⧇ āĻŦā§āϝāĻŦāĻšā§ƒāϤ āĻšāϝāĻŧ?

U-Net āĻšāϞ āĻāĻ•āϟāĻŋ āϏ⧇āĻ—āĻŽā§‡āĻ¨ā§āĻŸā§‡āĻļāύ āφāĻ°ā§āĻ•āĻŋāĻŸā§‡āĻ•āϚāĻžāϰ āϝāĻž āĻĒā§āϰāϤāĻŋāϟāĻŋ āĻĒāĻŋāĻ•ā§āϏ⧇āϞāϕ⧇ āϞ⧇āĻŦ⧇āϞ āĻ•āϰ⧇, āϝāĻž āϟāĻŋāωāĻŽāĻžāϰ āĻŦāĻž āĻ…āĻ™ā§āĻ—āϗ⧁āϞāĻŋāϰ āĻŽāϤ⧋ āĻ•āĻžāĻ āĻžāĻŽā§‹āϰ āĻŦāĻ°ā§āĻŖāύāĻž āĻ•āϰāĻžāϰ āϜāĻ¨ā§āϝ āφāĻĻāĻ°ā§āĻļāĨ¤

What was the ScreenTrustCAD study design for screening mammograms?

ScreenTrustCAD was a prospective paired-reader study in which two radiologists and AI CAD independently interpreted mammograms before consensus discussion.

āĻļāĻŋāĻ–āϤ⧇ āĻĨāĻžāϕ⧁āύ

āϏāĻŽā§āĻĒāĻ°ā§āĻ•āĻŋāϤ āĻ—āĻžāχāĻĄ

āĻāχ āĻŦāĻŋāώāϝāĻŧ⧇āϰ āϜāĻ¨ā§āϝ āĻŦāĻžāĻ›āĻžāχ āĻ•āϰāĻž āφāϰāĻ“ āĻ—āĻžāχāĻĄ

āĻĒāϰāĻŦāĻ°ā§āϤ⧀ āφāĻĒāĻĒāϰāĻŦāĻ°ā§āϤ⧀ āĻ—āĻžāχāĻĄ

āϚ⧁āĻ•ā§āϤāĻŋ āĻĒāĻ°ā§āϝāĻžāϞ⧋āϚāύāĻžāϝāĻŧ AI

āĻļāĻŋāĻ˛ā§āĻĒ

āĻāĻ•āϟāĻŋ āĻŦāĻŋāύāĻžāĻŽā§‚āĻ˛ā§āϝ⧇ AI āĻļāĻ‚āϏāĻžāĻĒāĻ¤ā§āϰ āĻĒāĻžāύāĻāĻ•āϟāĻŋ āϏāĻ‚āĻ•ā§āώāĻŋāĻĒā§āϤ āĻŦāĻŋāύāĻžāĻŽā§‚āĻ˛ā§āϝ⧇ āϕ⧋āĻ°ā§āϏ āĻāĻŦāĻ‚ āĻĒāϰ⧀āĻ•ā§āώāĻž. āϕ⧋āύ⧋ āĻ–āϰāϚ āύ⧇āχ, āϕ⧋āύ⧋ āĻ•āĻžāĻ°ā§āĻĄ āύ⧇āχāĨ¤ āĻĒā§āϰāĻžāϝāĻŧ 2.5 āϘāĻ¨ā§āϟāĻžāĨ¤āĻŦāĻŋāύāĻžāĻŽā§‚āĻ˛ā§āϝ⧇ āĻļ⧁āϰ⧁ āĻ•āϰ⧁āύ →